The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
Mesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved in the modulation of the tumor microenvironment (TME). With the advancement of nanotechnology, exosomes, especially exosomes secreted by MSCs, have been found to play an important role in the initiation and devel...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1214190/full |
_version_ | 1797741408245776384 |
---|---|
author | You Zhou Yuqing Dong Aixue Zhang Jibin Wu Qiang Sun |
author_facet | You Zhou Yuqing Dong Aixue Zhang Jibin Wu Qiang Sun |
author_sort | You Zhou |
collection | DOAJ |
description | Mesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved in the modulation of the tumor microenvironment (TME). With the advancement of nanotechnology, exosomes, especially exosomes secreted by MSCs, have been found to play an important role in the initiation and development of tumors. In recent years, nanobiotechnology and bioengineering technology have been gradually developed to detect and identify exosomes for diagnosis and modify exosomes for tumor treatment. Several novel therapeutic strategies bioengineer exosomes to carry drugs, proteins, and RNAs, and further deliver their encapsulated cargoes to cancer cells through the properties of exosomes. The unique properties of exosomes in cancer treatment include targeting, low immunogenicity, flexibility in modification, and high biological barrier permeability. Nevertheless, the current comprehensive understanding of the roles of MSCs and their secreted exosomes in cancer development remain inadequate. It is necessary to better understand/update the mechanism of action of MSCs-secreted exosomes in cancer development, providing insights for better modification of exosomes through bioengineering technology and nanobiotechnology. Therefore, this review focuses on the role of MSCs-secreted exosomes and bioengineered exosomes in the development, progression, diagnosis, and treatment of cancer. |
first_indexed | 2024-03-12T14:26:16Z |
format | Article |
id | doaj.art-637b3f42c4024132ad5537e0d41619c0 |
institution | Directory Open Access Journal |
issn | 2296-4185 |
language | English |
last_indexed | 2024-03-12T14:26:16Z |
publishDate | 2023-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Bioengineering and Biotechnology |
spelling | doaj.art-637b3f42c4024132ad5537e0d41619c02023-08-18T05:23:42ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-08-011110.3389/fbioe.2023.12141901214190The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancerYou Zhou0Yuqing Dong1Aixue Zhang2Jibin Wu3Qiang Sun4Department of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaChina Medical University and Department of Pathology, Shenyang, ChinaDepartment of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaDepartment of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaDepartment of Plastic Surgery, The First Hospital of China Medical University, Shenyang, ChinaMesenchymal stem cells (MSCs), one of the most common types of stem cells, are involved in the modulation of the tumor microenvironment (TME). With the advancement of nanotechnology, exosomes, especially exosomes secreted by MSCs, have been found to play an important role in the initiation and development of tumors. In recent years, nanobiotechnology and bioengineering technology have been gradually developed to detect and identify exosomes for diagnosis and modify exosomes for tumor treatment. Several novel therapeutic strategies bioengineer exosomes to carry drugs, proteins, and RNAs, and further deliver their encapsulated cargoes to cancer cells through the properties of exosomes. The unique properties of exosomes in cancer treatment include targeting, low immunogenicity, flexibility in modification, and high biological barrier permeability. Nevertheless, the current comprehensive understanding of the roles of MSCs and their secreted exosomes in cancer development remain inadequate. It is necessary to better understand/update the mechanism of action of MSCs-secreted exosomes in cancer development, providing insights for better modification of exosomes through bioengineering technology and nanobiotechnology. Therefore, this review focuses on the role of MSCs-secreted exosomes and bioengineered exosomes in the development, progression, diagnosis, and treatment of cancer.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1214190/fullmesenchymal stem cellsexosomesbiotechnologycancer therapycancer diagnosis |
spellingShingle | You Zhou Yuqing Dong Aixue Zhang Jibin Wu Qiang Sun The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer Frontiers in Bioengineering and Biotechnology mesenchymal stem cells exosomes biotechnology cancer therapy cancer diagnosis |
title | The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer |
title_full | The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer |
title_fullStr | The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer |
title_full_unstemmed | The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer |
title_short | The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer |
title_sort | role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer |
topic | mesenchymal stem cells exosomes biotechnology cancer therapy cancer diagnosis |
url | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1214190/full |
work_keys_str_mv | AT youzhou theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT yuqingdong theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT aixuezhang theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT jibinwu theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT qiangsun theroleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT youzhou roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT yuqingdong roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT aixuezhang roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT jibinwu roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer AT qiangsun roleofmesenchymalstemcellsderivedexosomesasanovelnanobiotechnologytargetinthediagnosisandtreatmentofcancer |